PLUS1
12.88
0.00 (0.0%)
0.00 (0.0%)
Upgrade to Real-Time
Afterhours (Closed)
Best deals to access real time data! |
|
CHART Trader
Monthly Subscription
for only
|
|
Canadian Level 1 + USA
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Rafael Holdings Inc | RFL | NYSE | Common Stock |
| Price Change | Change Percent | Stock Price | Low Price | High Price | Open Price | Close Price | Last Traded  |
|
|---|---|---|---|---|---|---|---|---|
| 0.50 | 4.04% | 12.88 | 12.37 | 13.2327 | 12.38 | 12.38 | 20:00:00 |
| Stock Trades | Traded Volume | VWAP | Dollar Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 1,698 | 21,217 | $ 12.94 | $ 274,650 | 36,476 | 9.40 - 23.76 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:00:00 | 2,185 | $ 12.88 | USD |
Rafael Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 203.74M | 15.82M | 8.82M | $ 3.58M | $ - | -0.35 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| 211.63k | $ - | 0.00% | -5.13M | 1.20% |
Rafael News
| Date | Time | Source | News Article |
|---|---|---|---|
| 6/09/2020 | 17:28 | PR Newswire (US) | Rafael Holdings Reports Third Quarter Fiscal Year 2020.. |
| 5/12/2020 | 20:05 | PR Newswire (US) | The Barer Institute Signs LOI for Lab Space at 3.0.. |
| 3/05/2020 | 16:30 | PR Newswire (US) | Rafael Holdings Reports Second Quarter Fiscal Year 2020.. |
| 1/23/2020 | 09:00 | GlobeNewswire Inc. | LipoMedix Announces Publication of Positive Phase 1 Data for.. |
| 1/13/2020 | 17:30 | PR Newswire (US) | Barer Institute Announces Founding Board Members |
| 12/19/2019 | 17:30 | PR Newswire (US) | Rafael Holdings Launches Cancer Drug Development Initiative |
| 12/09/2019 | 16:30 | PR Newswire (US) | Rafael Holdings Reports First Quarter Fiscal Year 2020.. |
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical RFL Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 14.33 | 14.3345 | 12.19 | 12.87 | 22,940 | -1.45 | -10.12% |
| 1 Month | 14.19 | 15.16 | 12.19 | 14.16 | 41,372 | -1.31 | -9.23% |
| 3 Months | 12.50 | 18.21 | 11.44 | 14.27 | 30,974 | 0.38 | 3.04% |
| 6 Months | 18.47 | 23.76 | 9.40 | 15.92 | 38,649 | -5.59 | -30.27% |
| 1 Year | 18.35 | 23.76 | 9.40 | 16.39 | 37,607 | -5.47 | -29.81% |
| 3 Years | 18.35 | 23.76 | 9.40 | 16.39 | 37,607 | -5.47 | -29.81% |
| 5 Years | 18.35 | 23.76 | 9.40 | 16.39 | 37,607 | -5.47 | -29.81% |
Rafael Description
| Rafael Holdings includes commercial real estate assets and interests in two clinical-stage pharmaceutical companies backed by a strong and liquid balance sheet. Rafael's real estate holdings are comprised by a 20-story commercial office building and associated parking garage in Newark, New Jersey, an office/data center building in Piscataway, New Jersey and an office condominium in Israel. Rafael's pharmaceutical holdings include interests in two clinical-stage oncology companies - Rafael Pharmaceuticals and LipoMedix. Rafael Pharmaceuticals is developing therapies that exploit the metabolic differences between normal cells and cancer cells in both solid and liquid cancers. LipoMedix is developing liposomal prodrugs designed to enhance the efficacy of certain chemotherapeutic therapies. |
